Pandemic medicine: the management of advanced melanoma during COVID-19 by James R Patrinely, Douglas B Johnson

Get full text

Long-term outcomes in patients with immune checkpoint inhibitor induced pneumonitis by Douglas B Johnson, Andrea Davis, Julie A Bastarache

Get full text

Clinical and immunologic correlates of response to PD-1 blockade in a patient with metastatic renal medullary carcinoma by Igor Puzanov, Douglas B. Johnson, Kathryn E. Beckermann, Pradeep C. Jolly, Ju Y. Kim, Jennifer Bordeaux, W. Kimryn Rathmell

Get full text

Mucosal inflammation predicts response to systemic steroids in immune checkpoint inhibitor colitis by Melissa Lumish, Ryan J. Sullivan, Douglas B. Johnson, Michael Dougan, Anita Giobbie-Hurder, Meghan J Mooradian, Daniel Y Wang, Alexandra Coromilas, Tianqi Chen

Get full text

Impact of steroid dose and timing on efficacy of combination PD-1/CTLA-4 blockade by Nina B. Curkovic, Rebecca Irlmeier, Xue Bai, Can Cui, Fei Ye, Hannah R. Burnette, Aleigha R. Lawless, Juliane Andrade Czapla, Ryan Sullivan, Douglas B. Johnson

Get full text

Molecular analysis of immune checkpoint inhibitor associated erythema nodosum-like toxicity by Xiaopeng Sun, Margaret L. Axelrod, Paula I. Gonzalez-Ericsson, Violeta Sanchez, Violeta Sanchez, Yu Wang, Jonathan L. Curry, Elizabeth J. Phillips, Yaomin Xu, Douglas B. Johnson, Justin M. Balko

Get full text

Long-term survival follow-up for tebentafusp in previously treated metastatic uveal melanoma by Jessica C Hassel, Alexander N Shoushtari, Omid Hamid, Takami Sato, Paul Nathan, Marcus O Butler, Jason J Luke, Richard D Carvajal, Leonel Hernandez-Aya, Douglas B Johnson, Laura Collins, Enrique Espinosa, Joseph J Sacco, Serge Leyvraz, Alexandra Ikeguchi, Matthew Rioth, Chris Holland, Josep M Piulats

Get full text

Immune checkpoint inhibitors in patients with pre-existing psoriasis: safety and efficacy by Andrew Haydon, Jessica C Hassel, Jeffrey A Sosman, Sunandana Chandra, Ryan Sullivan, Mario E Lacouture, Matteo Carlino, Meghan J Mooradian, Alexander Menzies, Douglas B Johnson, Fei Ye, Prachi Bhave, Steven T Chen, Georgina Long, Allison Betof Warner, Briana Rose Halle, Farzana Y Zaman, Anna K Dewan, Rebecca Irlmeier, Paras Mehta, Nicholas R Kurtansky, Jacob S Choi, Tracey S Otto, Florentia Dimitriou, Veronica M Rotemberg

Get full text

Defining D-irAEs: consensus-based disease definitions for the diagnosis of dermatologic adverse events from immune checkpoint inhibitor therapy by Laura C Cappelli, Bernice Kwong, Jarushka Naidoo, Jonathan Leventhal, Mario E Lacouture, Meghan J Mooradian, Douglas B Johnson, Justine Cohen, Aparna Hegde, Steven T Chen, Riley Fadden, Leyre Zubiri, Shawn Kwatra, Ryan J Sullivan, Kerry L Reynolds, Allison Betof Warner, Yevgeniy R Semenov, Nicole R LeBoeuf, Krista M Rubin, Anna K Dewan, Alina Markova, Allireza Alloo, Daniel Q Bach, Amina Bougrine, Leeann Burton, Mariana Castells, Lauren Guggina, Victor Huang, Benjamin Kaffenberger, Daniela Kroshinsky, Cecilia Larocca, Jon McDunn, Jennifer Choi, Vinod Nambudiri, Caroline A Nelson, Anisha B Patel, Julia Pimkina, Johnathan Rine, Maxwell Sauder, Sheila Shaigany, Afreen Shariff

Get full text

Consensus disease definitions for ophthalmic immune-related adverse events of immune checkpoint inhibitors by Lauren A Dalvin, James Chodosh, Andrew G Lee, Clare L Fraser, Marc Dinkin, Michael Levy, Douglas B Johnson, Meghan Berkenstock, Edmund Tsui, John J Chen, Kerry L Reynolds, Prem S Subramanian, Lynn K Gordon, H Nida Sen, Michael K Yoon, Fiona Costello, Ninani Kombo, Amanda C Guidon, Bart K Chwalisz, Krista M Rubin, Sapna Gangaputra, Lucia Sobrin, Jon McDunn, Julia Pimkina, Johnathan Rine, Afreen Shariff, Suzanne K Freitag, Eileen L Chang, Renee Liu, Kiandokht Keyhanian, Katie Huynh, M Tariq Bhatti, Lindsey B DeLott, Robert A Egan, Michal Kramer, Anne-Marie Lobo-Chan, Dimosthenis Mantopoulos, George Papaliodis, Misha Pless

Get full text